Maarten van der Linden

Maarten van der Linden is the current CEO at BluSense Diagnostics. Prior to this, they served as the Chief Business Officer at 2cureX from January 2018 to July 2021. In this role, they were responsible for bringing the company from its research stage to a viable commercial entity that could bring its core product to the market. Maarten's key areas of responsibility included strategy development, stakeholder engagement, commercialization, and investor relations.

From March 2017 to December 2017, van der Linden worked as a management consultant in healthcare, with a focus on strategy and commercialization. Prior to this, they served as the Senior Director of Marketing for Molecular Diagnostics EMEA at Abbott from June 2014 to March 2017. In this role, they were responsible for global marketing initiatives for advanced staining solutions at Agilent Technologies from September 2010 to June 2014.

Maarten van der Linden has a Bachelor of Business Administration (BSc) from Intercollege Business School, Den Haag, and an Executive MBA from Henley Business School.

Some direct reports include John McCormack - Director, Platform Development, Claus Berner - Sales & Marketing Director, and Jessie Sun - President, BluSense Biotech.